ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

317 hedge funds and large institutions have $10.5B invested in Array Biopharma Inc in 2019 Q2 according to their latest regulatory filings, with 125 funds opening new positions, 69 increasing their positions, 96 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

12% less call options, than puts

Call options by funds: $141M | Put options by funds: $160M

28% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 96

Holders
317
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
28
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$141M
Puts
$160M
Net Calls
Net Calls Change

Top Buyers

1 +$269M
2 +$176M
3 +$160M
4
PC
Paulson & Co
New York
+$152M
5
MF
Magnetar Financial
Illinois
+$148M

Top Sellers

1 -$607M
2 -$371M
3 -$256M
4
PA
Perceptive Advisors
New York
-$148M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$128M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$25.2M
77
$25.1M
78
$24.9M
79
$23.1M
80
$22.3M
81
$21.8M
82
$21.2M
83
$20.8M
84
$20M
85
$19.9M
86
$19.5M
87
$19.3M
88
$18.9M
89
$18.8M
90
$18.5M
91
$17.7M
92
$17.2M
93
$17.1M
94
$17.1M
95
$17M
96
$15M
97
$14.7M
98
$14.5M
99
$14.5M
100
$14.2M